Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Plos One|May 19, 2018
Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control studyAdeline Heraudeau, Aurélien Delluc, Mickaël Le Henaff, et al.
Respiratory Medicine and Research|August 13, 2021
Screening for COPD in primary care, involving dentists, pharmacists, physiotherapists, nurses and general practitioners (the UNANIME pilot study)Baptiste Hourmant, Christophe Gut Gobert, Régis Plumet, et al.
Fertility and Sterility|December 7, 2010
Increased thrombin generation measured in the presence of thrombomodulin in women with early pregnancy lossLuc de Saint Martin, Jérôme Duchemin, Caroline Bohec, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 5, 2011
Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factorAurélien Delluc, Aurélie Rousseau, Céline Delluc, et al.
British Journal of Haematology|June 16, 2011
Site of venous thromboembolism and prothrombotic mutations according to body mass index. Results from the EDITH studyAurélien Delluc, Emmanuelle Le Moigne, Cécile Tromeur, et al.
Atherosclerosis|November 1, 2011
Lipid parameters, lipid lowering drugs and the risk of venous thromboembolismAurélien Delluc, Jean-Marc Malécot, Hélène Kerspern, et al.
Haematologica|January 5, 2019
Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trialFrancis Couturaud, Gilles Pernod, Emilie Presles, et al.
Thrombosis and Haemostasis|July 24, 2003
Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive proteinKarine Lacut, Emmanuel Oger, Grégoire Le Gal, et al.
Haematologica|April 12, 2003
High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderlyEmmanuel Oger, Karine Lacut, Patrick Van Dreden, et al.
Reproductive Biomedicine Online|June 13, 2019
Blood anti-Müllerian hormone is a possible determinant of recurrent early miscarriage, yet not conclusive in predicting a further miscarriageEstelle Leclercq, Luc de Saint Martin, Caroline Bohec, et al.
Pageof 12